Invasive Therapy for Chronic Venous Insuficiency

1. ALMEIDA, J. I., JAVIER, J. J., MACKAY, E. et al., First human use of cyanoacrylate adhesive for treat­ment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord, 2013, 1(2), p. 174–180.

2. BECKER, F., MENASSA, M., GABRIELLE, F. et al. What complementary examinations to demand in chronic venous insufficiency? Phlebologie, 1992, 45(3), p. 297–303; discussion 304–306.

3. BERGAN, J. J., SCHMID-SCHONBEIN, G.W. Therapeutic management of chronic venous insuffi­-
ciency: microcirculation as a target. Microcirculation, 2000, 7(6 Pt 2), p. S23–28.

4. BERGAN, J. J., SCHMID-SCHONBEIN, G. W., SMITH, P. D. et al. Chronic venous disease. N Engl J Med, 2006, 355(5), p. 488–498.

5. BIEMANS, A. A., KOCKAERT, M., AKKERSDIJK, G. P. et al., Comparing endovenous laser ablation, foam sclerotherapy, and conventional surgery for great saphenous varicose veins. J Vasc Surg, 2013, 58(3), p. 727–734 e1.

6. BOISSEAU, M. R. Pharmacological targets of drugs employed in chronic venous and lymphatic insuffi­ciency. Int Angiol, 2002, 21(2 Suppl 1), p. 33–39.

7. BOLLINGER, A., LEU, A. J., HOFFMANN, U. et al. Microvascular changes in venous disease: an update. Angiology, 1997, 48(1), p. 27–32.

8. BOOTUN, R., LANE, T. R., DAVIES, A. H. The advent of non-thermal, non-tumescent techniques for treatment of varicose veins. Phlebology, 2016, 31(1), p. 5–14.

9. BOURJEILY, G., PAIDAS, M., KHALIL, H. et al. Pulmonary embolism in pregnancy. Lancet, 2010, 375(9713), p. 500–512.

10. BRITTENDEN, J., COTTON, S. C., ELDERS, A. et al., A randomized trial comparing treatments for
varicose veins. N Engl J Med, 2014, 371(13), p.
1218–1227.

11. BURNAND, K. G. The physiology and hemodynamics of chronic venous insufficiency. Handbook of venous disorders, 2nd ed. New York, NY: Arnold; 2001: p. 49–57.

12. CAPRINI, J. A., PARTSCH, H., SIMMAN, R. Venous Ulcers. J Am Coll Clin Wound Spec, 2012, 4(3), p.
54–60.

13. CARRADICE, D. Superficial venous insufficiency from the infernal to the endothermal. Ann R Coll Surg Engl, 2014, 96(1): p. 5–10.

14. CARRADICE, D., MEKAKO, A. I., MAZARI, F. A. et al. Clinical and technical outcomes from a randomized clinical trial of endovenous laser ablation compared with conventional surgery for great saphenous varicose veins. Br J Surg, 2011, 98(8), p. 1117–1123.

15. CARRADICE, D., MEKAKO, A. I., MAZARI, F. A. et al., Randomized clinical trial of endovenous laser ablation compared with conventional surgery for great saphenous varicose veins. Br J Surg, 2011, 98(4), p. 501–510.

16. CARROLL, C., HUMMEL, S., LEAVISS, J. et al. Clinical effectiveness and cost-effectiveness of minimally invasive techniques to manage varicose veins: a systematic review and economic evaluation. Health Technol Assess, 2013, 17(48), p. i-xvi, 1–141.

17. COLERIDGE-SMITH, P., LOK, C., RAMELET, A. A. Venous leg ulcer: a meta-analysis of adjunctive therapy with micronized purified flavonoid fraction. Eur J Vasc Endovasc Surg, 2005, 30(2), p. 198–208.

18. COLLARES, F. B., FAINTUCH, S., Varicose Veins. Theime Publishers, 2017.

19. CRITCHLEY, G., HANDA, A., MAW, A. et al., Complications of varicose vein surgery. Ann R Coll Surg Engl, 1997, 79(2), p. 105–110.

20. DARWOOD, R. J., THEIVACUMAR, N., DELLAGRAMMATICAS, D. et al. Randomized clinical trial comparing endovenous laser ablation with surgery for the treatment of primary great saphenous varicose veins. Br J Surg, 2008, 95(3), p. 294–301.

21. DEVIS, P., KNUTTINEN, M. G. Deep venous thrombosis in pregnancy: incidence, pathogenesis and endovascular management. Cardiovasc Diagn Ther, 2017, 7(Suppl 3), p. S309–S319.

22. EKLOF, B., RUTHERFORD, R. B., BERGAN, J. J. et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg, 2004, 40(6), p. 1248–1252.

23. ELIAS, S. Minimally invasive vein surgery: latest options for vein disease. Mt Sinai J Med, 2010, 77(3), p. 270–278.

24. ELIÁŠ, P., ŽIŽKA, J. Dopplerovská ultrasonografie. Nucleus, 1998, 1. vydání s. 150–155.  25. EVANS, C. J., FOWKES, F. G., RUCKLEY, C. V. et al. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh
Vein Study. J Epidemiol Community Health, 1999, 53(3), p. 149–153.

26. GALANOPOULOS, G., LAMBIDIS, C. Minimally invasive treatment of varicose veins: Endovenous
laser ablation (EVLA). Int J Surg, 2012, 10(3), p.
134–139.

27. GLOVICZKI, P., COMEROTA, A. J., DALSING, M. C. et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg, 2011, 53(5 Suppl), p. 2S48S.

28. GLOVICZKI, P., GLOVICZKI, M. L. Guidelines for the management of varicose veins. Phlebology, 2012, 27 Suppl 1, p. 2–9.

29. GSCHWANDTNER, M. E., EHRINGER, H., Microcirculation in chronic venous insufficiency. Vasc Med, 2001, 6(3), p. 169–179.

30. CHRISTENSON, J. T., GUEDDI, S., GEMAYEL, G. et al. Prospective randomized trial comparing endovenous laser ablation and surgery for treatment of primary great saphenous varicose veins with a 2-year follow-up. J Vasc Surg, 2010, 52(5), p. 1234–1241.

31. JANTET, G. Symptoms and signs in chronic venous insufficiency. Phlebolymphology, 27, p. 2–3.

32. KAPPERT, A. Angiológia učebnica a atlas. Choroby tepien, žíl, vlásečnic a lymfatických ciev. Osveta, 1987, s. 24.

33. MILLER, G. V., LEWIS, W. G., SAINSBURY, J. R. et al. Morbidity of varicose vein surgery: auditing the benefit of changing clinical practice. Ann R Coll Surg Engl, 1996, 78(4), p. 345–349.

34. MIZUNO, Y., PUCA, A. A., O‘BRIEN, K. F. et al.
Genomic organization and single-nucleotide polymorphism map of desmuslin, a novel intermediate filament protein on chromosome 15q26.3. BMC
Genet, 2001, 2, p. 8.

35. MOORE, P. Zrození člověka. Embryologie s klinickým zaměřením. Praha ISV, 2002.

36. MORRISON, N., GIBSON, K., MCENROE, S. et al. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg, 2015, 61(4), p. 985–994.

37. NAVRÁTIL, L., ROSINA, J. et al. Medicínská biofyzika. Praha, Grada, 2005, 1. vydání: s. 524.

38. NAVRÁTILOVÁ, Z. Kompresivní terapie u žilních onemocnění. Interní Med, 2008(10), p. 449–455.

39. NEHLER, M. R., PORTER, J. M. The lower extremity venous system. Part II: The pathophysiology of chronic venous insufficiency. Perspect VascSurg, 1992(5), p. 81.

40. NICOLAIDES, A. N., ALLEGRA, C., BERGAN, J. et al. Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence. Int Angiol, 2008, 27(1), p. 1–59.

41. NICOLAIDES, A. N., CARDIOVASCULAR DISEASE, E., RESEARCH, T. et al. Investigation of chronic venous insufficiency: A consensus statement (France, March 5–9, 1997). Circulation, 2000, 102(20), p. E126–163.

42. O‘DONNELL, T.F., JR., PASSMAN, M. A. Clinical practice guidelines of the Society for Vascular Surgery (SVS) and the American Venous Forum (AVF) – Management of venous leg ulcers. Introduction.
J Vasc Surg, 2014, 60(2 Suppl), p. 1S–2S.

43. PIAZZA, G. Varicose veins. Circulation, 2014, 130(7), p. 582–587.

44. PROEBSTLE, T. M., MOEHLER, T., HERDEMANN, S. Reduced recanalization rates of the great saphenous vein after endovenous laser treatment with increased energy dosing: definition of a threshold for the endovenous fluence equivalent. J Vasc Surg, 2006, 44(4), p. 834–839.

45. RASMUSSEN, L. H., BJOERN, L., LAWAETZ, M. et al. Randomised clinical trial comparing endovenous laser ablation with stripping of the great saphenous vein: clinical outcome and recurrence after 2 years. Eur J Vasc Endovasc Surg, 2010, 39(5), p. 630–635.

46. RASMUSSEN, L. H., LAWAETZ, M., BJOERN, L. et al. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Br J Surg, 2011, 98(8), p. 107–187.

47. ROZTOČIL, K., Venotonika – komu a která? Angiologie, 2007, s. 51–53.

48. SANCHEZ, C., CHINN, B. T. Hemorrhoids. Clin Colon Rectal Surg, 2011, 24(1), p. 5–13.

49. SERVELLE, M. Klippel and Trenaunay‘s syndrome. 768 operated cases. Ann Surg, 1985, 201(3), p.
365–373.

50. SIRIBUMRUNGWONG, B., NOORIT, P., WILASRUSMEE, C. et al., A systematic review and meta-analysis of randomised controlled trials comparing endovenous ablation and surgical intervention in patients with varicose vein. Eur J Vasc Endovasc Surg, 2012, 44(2), p. 214–223.

51. TASSIE, E., SCOTLAND, G., BRITTENDEN, J. et al. Cost-effectiveness of ultrasound-guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. Br J Surg, 2014, 101(12), p. 1532–1540.

52. VALENTA, J. Základy chirurgie. Karolinum, 2003.
2. vydání. s. 191, 192, 195.

53. VAN DEN BOS, R. R., KOCKAERT, M. A., NEUMANN, H. A. et al., Technical review of endovenous laser therapy for varicose veins. Eur J Vasc Endovasc Surg, 2008, 35(1), p. 88–95.

54. VAN DEN BOS, R. R., MILLERET, R., NEUMANN, M. et al., Proof-of-principle study of steam abla­-
tion as novel thermal therapy for saphenous varicose veins. J Vasc Surg, 2011, 53(1), p. 181–186.

55. VAN EEKEREN, R. R., BOERSMA, D., KONIJN,
V. et al. Postoperative pain and early quality of life after radiofrequency ablation and mechanochemical endovenous ablation of incompetent great saphenous veins. J Vasc Surg, 2013, 57(2), p. 445–450.

56. VAN RUIJVEN, P. W., VAN DEN BOS, R. R., ALAZARD, L. M. et al. Temperature measurements for dose-finding in steam ablation. J Vasc Surg, 2011, 53(5), p. 1454–1456.

57. VENTURI, M., BONAVINA, L., ANNONI, F. et al. Biochemical assay of collagen and elastin in the normal and varicose vein wall. J Surg Res, 1996, 60(1), p. 245–248.

58. WEST, J. B. The birth of clinical body plethysmography: it was a good week. J Clin Invest, 2004, 114(8), p. 1043–1045.

59. WHIDDON, L. L. Advances in the treatment of superficial venous insufficiency of the lower extremities. Proc (Bayl Univ Med Cent), 2007, 20(2), p.
136–139.

60. XIAO, Y., HUANG, Z., YIN, H. et al. Desmuslin gene knockdown causes altered expression of phenotype markers and differentiation of saphenous vein smooth muscle cells. J Vasc Surg, 2010, 52(3), p. 684–690.

61. YIN, H., ZHANG, X., WANG, J. et al. Downregulation of desmuslin in primary vein incompetence.
J Vasc Surg, 2006, 43(2), p. 372–378.